AgomAb Therapeutics NV
$6.85
3
+$0.13+1.93% 21:00 Today
+$0.05+0.73%22:18After hours
Statistics
Day High
7.16
Day Low
6.67
52W High
17.82
52W Low
6.52
Volume
40,243
Avg. Volume
148,304
Mkt Cap
337.35M
P/E Ratio
-
Dividend Yield
-
Dividend
-
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AGMB. It's not an investment recommendation.
Allianz
2
ALV.XETRA
Mercedes-Benz Group
2
MBG.XETRA
Basf
2
BAS.XETRA
Muenchener Rueckversicherungs-Gesellschaft
2
MUV2.F
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Show More
CEO
Tim Knotnerus
Employees
62
Country
Sweden
ISIN
US00860C1027
WKN
000A421MA
Listings
0 Comments
Share your thoughts
FAQs
What is AgomAb Therapeutics NV stock price today?▼
The current price of AGMB is $6.85 USD — it has increased by +1.93% in the past 24 hours. Watch AgomAb Therapeutics NV stock price performance more closely on the chart.
What is AgomAb Therapeutics NV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange AgomAb Therapeutics NV stocks are traded under the ticker AGMB.
What is AgomAb Therapeutics NV market cap?▼
Today AgomAb Therapeutics NV has the market capitalization of 337.35M
How many employees does AgomAb Therapeutics NV have?▼
As of November 3, 2026, the company has 62 employees.
In which sector is AgomAb Therapeutics NV located?▼
AgomAb Therapeutics NV operates in the Health & Wellness sector.
When did AgomAb Therapeutics NV complete a stock split?▼
AgomAb Therapeutics NV has not had any recent stock splits.
Where is AgomAb Therapeutics NV headquartered?▼
AgomAb Therapeutics NV is headquartered in Antwerp, Sweden.